| Model Number |
NA-U200H-8019 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Pulmonary Embolism (1498); Abdominal Pain (1685); Bradycardia (1751); Fever (1858); Hemorrhage/Blood Loss/Bleeding (1888); Laceration(s) (1946); Perforation (2001); Peritonitis (2252); Respiratory Failure (2484); Aspiration Pneumonitis (4455); Pancreatitis (4481); Cholangitis (4821)
|
| Date of Event |
01/02/2023
|
|
Type of Reportable Event
|
Serious Injury
|
|
Event or Problem Description
|
|
Olympus reviewed the article, "ercp using balloon-assisted endoscopes versus eus-guided treatment for common bile duct stones in roux-en-y gastrectomy." consecutive patients who had previous roux-en-y (r-y) gastrectomy undergoing balloon-assisted endoscope (be-ercp) or eus-guided antegrade treatment (eus-ag) for common bile duct (cbd) stones in 16 centers were retrospectively analyzed.Patients who underwent endoscopic interventions between january 2009 and march 2020 were enrolled.Balloon-assisted endoscopic retrograde cholangiopancreatography (ercp): type of adverse events/number of patients pancreatitis (23) cholangitis (7) cholecystitis (1) major or minor perforation (15) laceration (3) bleeding (3) aspiration pneumoniae (4) respiratory failure (2) pulmonary embolism (1) bradycardia (1) endoscopic ultrasound (eus)-guided antegrade treatment: type of adverse events/number of patients cholangitis (3) cholecystitis (1) bile peritonitis (2) abdominal pain with fever (5) the selection of the intervention was at the discretion of endo- scopists.When the initial procedure failed, an alternative treatment was chosen from another endoscopic intervention, percutaneous transhepatic biliary drainage, surgical care, and conservative management.
|
| |
|
Additional Manufacturer Narrative
|
|
This report is related to the following linked patient identifiers: (b)(6).The device was not returned.Attempts were performed to obtain additional information, but no response was received.Should additional relevant information become available, a supplemental report will be submitted.
|
| |
|
Additional Manufacturer Narrative
|
|
This report is being supplemented to provide additional information, based on the legal manufacturer's final investigation.The device history record was unable to be reviewed for this device, since the serial and/or lot number was not provided.However, olympus only releases products to market that meet all manufacturing specifications and final product release criteria.Based on the results of the investigation, a relationship between the device and the adverse event cannot be confirmed.There was no complaint reported on the subject device.There is no evidence of an olympus device malfunction.Therefore, the root cause cannot be determined.Olympus will continue to monitor field performance for this device.
|
| |
|
Search Alerts/Recalls
|